Induction of specific autoimmune response to leukaemic cells in human leukaemia patient by chemically tagged normal "O" group white blood cells.
D000017:ABO Blood-Group System; D000328:Adult; D000372:Agglutination Tests; D000906:Antibodies; D000917:Antibody Formation; D002462:Cell Membrane / Q000276:immunology; D006801:Humans; D007112:Immunity, Maternally-Acquired; D007116:Immunization, Passive; D005779:Immunodiffusion; D007519:Isoantigens; D007945:Leukemia, Lymphoid / Q000276:immunology*; D007962:Leukocytes / Q000187:drug effects / Q000276:immunology / Q000378:metabolism*; D008297:Male; D015122:Mercaptopurine / Q000008:administration & dosage; D009578:Nitrobenzenes / Q000494:pharmacology; D011233:Precipitin Tests; D011239:Prednisolone / Q000627:therapeutic use
D000017:ABO Blood-Group System; D000906:Antibodies; D007519:Isoantigens; D009578:Nitrobenzenes; D011239:Prednisolone; D015122:Mercaptopurine